骨质疏松患者拔牙后抗骨吸收药物使用与颌骨骨坏死的关键洞察:临床与锥形束CT评估
该回顾性队列研究纳入176例骨质疏松患者,比较接受抗骨吸收药物(ARD)治疗者(78例,224颗牙)与年龄、性别、牙齿匹配的对照组(98例,227颗牙)拔牙后的临床与锥形束CT(CBCT)表现。ARD治疗组4例(5%)和5个位点(2%)发生药物相关性颌骨骨坏死(MRONJ),硬骨板增厚更明显,平均黏膜愈合时间4.4周 vs 对照组2.6周。皮质类固醇使用和多根牙显著增加MRONJ风险;骨死骨是骨坏死的影像学指标。
要点
- ARD治疗组4例(5%)和5个位点(2%)拔牙后发生MRONJ。
- ARD治疗组平均黏膜愈合时间4.4周,长于对照组的2.6周。
- 皮质类固醇使用和多根牙在ARD组中显著增加MRONJ风险。
核心结论
- 接受ARD治疗的骨质疏松患者可能表现出硬骨板增厚和术后愈合时间延长。
- 在这些患者中,多根牙发生MRONJ的风险高于单根牙。
- 死骨形成是骨坏死的影像学指标。
研究设计与样本
- 回顾性队列研究,收集176例患者的临床与CBCT数据。
- 研究组78例(224颗拔牙)接受ARD治疗并有术前CBCT;按年龄、性别和牙齿匹配的对照组98例(227颗拔牙)。
- 影像学检查由三名经过校准的检查者独立完成;统计方法包括卡方检验、Fisher精确检验、Mann-Whitney U检验和t检验,显著性水平设为p ≤ 0.05。
主要发现
- 研究组中4例患者(5%)和5个位点(2%)拔牙后发生MRONJ。
- ARD治疗组硬骨板增厚显著多于对照组,平均黏膜愈合时间4.4周 vs 对照组2.6周。
- 研究组中MRONJ风险随皮质类固醇使用和多根牙而显著增加。
- 双膦酸盐与地舒单抗使用者在断层影像特征上无显著差异(p > 0.05)。
- 骨死骨仅见于术后骨暴露或组织学证实骨坏死的骨质疏松患者。
关键数值与推荐
- 研究组MRONJ发生率:4例患者(5%),5个位点(2%)。
- 平均黏膜愈合时间:ARD组4.4周 vs 对照组2.6周。
- 双膦酸盐与地舒单抗的断层影像特征比较p > 0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This study investigates the effects of antiresorptive drugs and risk factors for medication-related osteonecrosis of the jaws in osteoporotic patients undergoing tooth extraction. Among the findings, antiresorptive-treated patients had thicker lamina dura and longer healing times. Additionally, corticosteroid intake and multi-rooted teeth carried a higher osteonecrosis risk. Bone sequestrum indicated osteonecrosis. PURPOSE: To describe the effects of antiresorptive drugs (ARD) in the maxilla and mandible and risk factors for medication-related osteonecrosis of the jaws (MRONJ) in osteoporotic patients undergoing tooth extractions using clinical data and cone beam computed tomography (CBCT). METHODS: This retrospective cohort study collected clinical and CBCT data from 176 patients. The study group (n = 78; 224 extractions) received ARD treatment, underwent tooth extraction, and had a pre-operative CBCT. Additionally, age-, sex-, and tooth-matched controls were selected (n = 98; 227 extractions). Radiographic examinations were performed independently by three calibrated examiners. Statistical analysis included Chi-square, Fisher's exact, Mann-Whitney U, and t-tests to contrast clinical and radiographic data between study and control, MRONJ + and MRONJ - , and bisphosphonate and denosumab patients/sites. Significance was set at p ≤ 0.05. RESULTS: From the study group, 4 patients (5%) and 5 sites (2%) developed MRONJ after tooth extraction. ARD-treated patients exhibited significantly more thickening of the lamina dura and a longer average mucosal healing time (4.4 weeks) than controls (2.6 weeks). In the study group, MRONJ risk significantly increased with corticosteroid intake and in multi-rooted teeth. No significant differences between bisphosphonates and denosumab use were seen in the tomographic features (p > 0.05). Lastly, bone sequestrum was exclusively observed in osteoporotic patients, who exhibited post-operative exposed bone or histological evidence of osteonecrosis. CONCLUSION: Osteoporotic patients under ARD may exhibit thickening of the lamina dura and prolonged post-operative healing. Among these patients, multi-rooted teeth are at higher risk for MRONJ than single-rooted teeth. Sequester formation is a radiographic indicator of osteonecrosis.
引用
- Moreno-Rabié C, Fontenele RC, Oliveira-Santos N, et al. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment. Osteoporos Int. 2024. PMID: 38767743. doi:10.1007/s00198-024-07108-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。